Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Harvey

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Mbio|April 11, 2019
Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific AntibodiesJin Gao, Laura Couzens, David F Burke, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Emergence and antigenic characterisation of influenza A(H3N2) viruses with hemagglutinin substitutions N158K and K189R during the 2024/25 influenza seasonBjörn Koel, Alexander Mp Byrne, Sam Turner, et al.
The Biochemical Journal|July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicaseJingkun Zeng, Florian Weissmann, Agustina P Bertolin, et al.
Science Translational Medicine|July 27, 2022
SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodiesKevin W Ng, Nikhil Faulkner, Katja Finsterbusch, et al.
Vaccine|March 8, 2025
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeuticsGiulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Influenza and Other Respiratory Viruses|August 14, 2025
Improved Resolution of Influenza Vaccination Responses With High-Throughput Live Virus MicroneutralisationLorin Adams, Phoebe Stevenson-Leggett, Jia Le Lee, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025Caroline Kikawa, John Huddleston, Andrea N Loes, et al.
Virus Evolution|November 25, 2025
Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025Caroline Kikawa, John Huddleston, Andrea N Loes, et al.
Influenza and Other Respiratory Viruses|February 13, 2026
Nomenclature for Tracking of Genetic Variation of Seasonal Influenza VirusesRichard A Neher, John Huddleston, Trevor Bedford, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variantsTimothy W Russell, Hermaleigh Townsley, Sam Abbott, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Mbio|April 11, 2019
Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific AntibodiesJin Gao, Laura Couzens, David F Burke, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Emergence and antigenic characterisation of influenza A(H3N2) viruses with hemagglutinin substitutions N158K and K189R during the 2024/25 influenza seasonBjörn Koel, Alexander Mp Byrne, Sam Turner, et al.
The Biochemical Journal|July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicaseJingkun Zeng, Florian Weissmann, Agustina P Bertolin, et al.
Science Translational Medicine|July 27, 2022
SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodiesKevin W Ng, Nikhil Faulkner, Katja Finsterbusch, et al.
Vaccine|March 8, 2025
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeuticsGiulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Influenza and Other Respiratory Viruses|August 14, 2025
Improved Resolution of Influenza Vaccination Responses With High-Throughput Live Virus MicroneutralisationLorin Adams, Phoebe Stevenson-Leggett, Jia Le Lee, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025Caroline Kikawa, John Huddleston, Andrea N Loes, et al.
Virus Evolution|November 25, 2025
Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025Caroline Kikawa, John Huddleston, Andrea N Loes, et al.
Influenza and Other Respiratory Viruses|February 13, 2026
Nomenclature for Tracking of Genetic Variation of Seasonal Influenza VirusesRichard A Neher, John Huddleston, Trevor Bedford, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variantsTimothy W Russell, Hermaleigh Townsley, Sam Abbott, et al.
Pageof 7